Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 88 entries
Sorted by: Best Match Show Resources per page
Does knowing pre-operative penile length influence patient satisfaction post penile prosthesis implantation?.

International journal of impotence research

Palasi S, Howell S, Green TP, Kannady C, Slaughter KB, Yang B, Panuganti S, Saavedra-Belaunde JA, Clavell-Hernandez J, Wang R.
PMID: 34580432
Int J Impot Res. 2021 Sep 27; doi: 10.1038/s41443-021-00472-1. Epub 2021 Sep 27.

Patients who undergo penile prosthesis implantation as treatment for erectile dysfunction commonly complain of penile shortening after implantation. We conducted a study to determine whether knowledge of pre-operative stretched penile length measurement influences patient satisfaction. This prospective study consisted...

Cite
Palasi S, Howell S, Green TP, et al. Does knowing pre-operative penile length influence patient satisfaction post penile prosthesis implantation?. Int J Impot Res. 2021;doi: 10.1038/s41443-021-00472-1.
Palasi, S., Howell, S., Green, T. P., Kannady, C., Slaughter, K. B., Yang, B., Panuganti, S., Saavedra-Belaunde, J. A., Clavell-Hernandez, J., & Wang, R. (2021). Does knowing pre-operative penile length influence patient satisfaction post penile prosthesis implantation?. International journal of impotence research, . https://doi.org/10.1038/s41443-021-00472-1
Palasi, Stephen, et al. "Does knowing pre-operative penile length influence patient satisfaction post penile prosthesis implantation?." International journal of impotence research vol. (2021). doi: https://doi.org/10.1038/s41443-021-00472-1
Palasi S, Howell S, Green TP, Kannady C, Slaughter KB, Yang B, Panuganti S, Saavedra-Belaunde JA, Clavell-Hernandez J, Wang R. Does knowing pre-operative penile length influence patient satisfaction post penile prosthesis implantation?. Int J Impot Res. 2021 Sep 27; doi: 10.1038/s41443-021-00472-1. Epub 2021 Sep 27. PMID: 34580432.
Copy Download .nbib Format: NLM
Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks.

Journal of imaging

Fysikopoulos E, Rouchota M, Eleftheriadis V, Gatsiou CA, Pilatis I, Sarpaki S, Loudos G, Kostopoulos S, Glotsos D.
PMID: 34940729
J Imaging. 2021 Dec 03;7(12). doi: 10.3390/jimaging7120262.

In the current work, a pix2pix conditional generative adversarial network has been evaluated as a potential solution for generating adequately accurate synthesized morphological X-ray images by translating standard photographic images of mice. Such an approach will benefit 2D functional...

Cite
Fysikopoulos E, Rouchota M, Eleftheriadis V, et al. Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks. J Imaging. 2021;7(12)doi: 10.3390/jimaging7120262.
Fysikopoulos, E., Rouchota, M., Eleftheriadis, V., Gatsiou, C. A., Pilatis, I., Sarpaki, S., Loudos, G., Kostopoulos, S., & Glotsos, D. (2021). Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks. Journal of imaging, 7(12), . https://doi.org/10.3390/jimaging7120262
Fysikopoulos, Eleftherios, et al. "Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks." Journal of imaging vol. 7,12 (2021). doi: https://doi.org/10.3390/jimaging7120262
Fysikopoulos E, Rouchota M, Eleftheriadis V, Gatsiou CA, Pilatis I, Sarpaki S, Loudos G, Kostopoulos S, Glotsos D. Optical to Planar X-ray Mouse Image Mapping in Preclinical Nuclear Medicine Using Conditional Adversarial Networks. J Imaging. 2021 Dec 03;7(12). doi: 10.3390/jimaging7120262. PMID: 34940729.
Copy Download .nbib Format: NLM
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Cancer

Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A.
PMID: 34643947
Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13.

BACKGROUND: The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study investigated the benefit of neoadjuvant chemotherapy according to prognostic stratification based on the Sarculator nomogram for STS.METHODS: This study analyzed data from...

Cite
Pasquali S, Palmerini E, Quagliuolo V, et al. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2021;128(1):85-93doi: 10.1002/cncr.33895.
Pasquali, S., Palmerini, E., Quagliuolo, V., Martin-Broto, J., Lopez-Pousa, A., Grignani, G., Brunello, A., Blay, J. Y., Tendero, O., Diaz-Beveridge, R., Ferraresi, V., Lugowska, I., Infante, G., Braglia, L., Merlo, D. F., Fontana, V., Marchesi, E., Donati, D. M., Palassini, E., Bianchi, G., Marrari, A., Morosi, C., Stacchiotti, S., Bagué, S., Coindre, J. M., Dei Tos, A. P., Picci, P., Bruzzi, P., Miceli, R., Casali, P. G., & Gronchi, A. (2022). Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer, 128(1), 85-93. https://doi.org/10.1002/cncr.33895
Pasquali, Sandro, et al. "Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial." Cancer vol. 128,1 (2022): 85-93. doi: https://doi.org/10.1002/cncr.33895
Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. Cancer. 2022 Jan 01;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13. PMID: 34643947.
Copy Download .nbib Format: NLM
Mutational Analysis of the GXXXG/A Motifs in the Human Na.

Frontiers in molecular biosciences

Palatini M, Müller SF, Lowjaga KAAT, Noppes S, Alber J, Lehmann F, Goldmann N, Glebe D, Geyer J.
PMID: 34239896
Front Mol Biosci. 2021 Jun 22;8:699443. doi: 10.3389/fmolb.2021.699443. eCollection 2021.

Homodimerization is essential for plasma membrane sorting of the liver bile acid transporter NTCP and its function as Hepatitis B/D Virus (HBV/HDV) receptor. However, the protein domains involved in NTCP dimerization are unknown. NTCP bears two potential GXXXG/A dimerization...

Cite
Palatini M, Müller SF, Lowjaga KAAT, et al. Mutational Analysis of the GXXXG/A Motifs in the Human Na. Front Mol Biosci. 2021;8:699443doi: 10.3389/fmolb.2021.699443.
Palatini, M., Müller, S. F., Lowjaga, K. A. A. T., Noppes, S., Alber, J., Lehmann, F., Goldmann, N., Glebe, D., & Geyer, J. (2021). Mutational Analysis of the GXXXG/A Motifs in the Human Na. Frontiers in molecular biosciences, 8699443. https://doi.org/10.3389/fmolb.2021.699443
Palatini, Massimo, et al. "Mutational Analysis of the GXXXG/A Motifs in the Human Na." Frontiers in molecular biosciences vol. 8 (2021): 699443. doi: https://doi.org/10.3389/fmolb.2021.699443
Palatini M, Müller SF, Lowjaga KAAT, Noppes S, Alber J, Lehmann F, Goldmann N, Glebe D, Geyer J. Mutational Analysis of the GXXXG/A Motifs in the Human Na. Front Mol Biosci. 2021 Jun 22;8:699443. doi: 10.3389/fmolb.2021.699443. eCollection 2021. PMID: 34239896; PMCID: PMC8257933.
Copy Download .nbib Format: NLM
Reply.

Journal of hypertension

Palatini P, Julius S, Zanchetti A.
PMID: 27579707
J Hypertens. 2016 Oct;34(10):2103-4. doi: 10.1097/HJH.0000000000001055.

No abstract available.

Cite
Palatini P, Julius S, Zanchetti A. Reply. J Hypertens. 2016;34(10):2103-4doi: 10.1097/HJH.0000000000001055.
Palatini, P., Julius, S., & Zanchetti, A. (2016). Reply. Journal of hypertension, 34(10), 2103-4. https://doi.org/10.1097/HJH.0000000000001055
Palatini, Paolo, et al. "Reply." Journal of hypertension vol. 34,10 (2016): 2103-4. doi: https://doi.org/10.1097/HJH.0000000000001055
Palatini P, Julius S, Zanchetti A. Reply. J Hypertens. 2016 Oct;34(10):2103-4. doi: 10.1097/HJH.0000000000001055. PMID: 27579707.
Copy Download .nbib Format: NLM
Accuracy of the oscillometric method for the measurement of heart rate at rest and during mild exercise.

Journal of hypertension

Palatini P, Lazzaretto I, Fontana U, Fania C.
PMID: 34992196
J Hypertens. 2022 Feb 01;40(2):240-244. doi: 10.1097/HJH.0000000000002998.

OBJECTIVE: Whether oscillometric devices provide accurate measurements of heart rate (HR) is not known. Our aim was to determine the accuracy of an oscillometric device for the measurement of HR during rest and exercise.METHODS: The Microlife WatchBP O3, a...

Cite
Palatini P, Lazzaretto I, Fontana U, et al. Accuracy of the oscillometric method for the measurement of heart rate at rest and during mild exercise. J Hypertens. 2022;40(2):240-244doi: 10.1097/HJH.0000000000002998.
Palatini, P., Lazzaretto, I., Fontana, U., & Fania, C. (2022). Accuracy of the oscillometric method for the measurement of heart rate at rest and during mild exercise. Journal of hypertension, 40(2), 240-244. https://doi.org/10.1097/HJH.0000000000002998
Palatini, Paolo, et al. "Accuracy of the oscillometric method for the measurement of heart rate at rest and during mild exercise." Journal of hypertension vol. 40,2 (2022): 240-244. doi: https://doi.org/10.1097/HJH.0000000000002998
Palatini P, Lazzaretto I, Fontana U, Fania C. Accuracy of the oscillometric method for the measurement of heart rate at rest and during mild exercise. J Hypertens. 2022 Feb 01;40(2):240-244. doi: 10.1097/HJH.0000000000002998. PMID: 34992196.
Copy Download .nbib Format: NLM
Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution.

Annals of surgical oncology

Danieli M, Barretta F, Fiore M, Radaelli S, Sangalli C, Barisella M, Stacchiotti S, Palassini E, Miceli R, Frezza AM, Callegaro D, Casali PG, Gronchi A.
PMID: 35000087
Ann Surg Oncol. 2022 Jan 08; doi: 10.1245/s10434-021-11189-2. Epub 2022 Jan 08.

BACKGROUND: The improved outcome of extremity soft tissue sarcoma patients surgically treated until 2007 at the authors' institution was previously reported. This study updates the analysis at a later follow-up and extends the patients' cohort to assess changes in...

Cite
Danieli M, Barretta F, Fiore M, et al. Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution. Ann Surg Oncol. 2022;doi: 10.1245/s10434-021-11189-2.
Danieli, M., Barretta, F., Fiore, M., Radaelli, S., Sangalli, C., Barisella, M., Stacchiotti, S., Palassini, E., Miceli, R., Frezza, A. M., Callegaro, D., Casali, P. G., & Gronchi, A. (2022). Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution. Annals of surgical oncology, . https://doi.org/10.1245/s10434-021-11189-2
Danieli, Maria, et al. "Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution." Annals of surgical oncology vol. (2022). doi: https://doi.org/10.1245/s10434-021-11189-2
Danieli M, Barretta F, Fiore M, Radaelli S, Sangalli C, Barisella M, Stacchiotti S, Palassini E, Miceli R, Frezza AM, Callegaro D, Casali PG, Gronchi A. Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution. Ann Surg Oncol. 2022 Jan 08; doi: 10.1245/s10434-021-11189-2. Epub 2022 Jan 08. PMID: 35000087.
Copy Download .nbib Format: NLM
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid.

European journal of preventive cardiology

Palatini P, Parati G, Virdis A, Reboldi G, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Verdecchia P, Angeli F, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Georgiopoulos G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C.
PMID: 33582757
Eur J Prev Cardiol. 2021 Feb 14; doi: 10.1093/eurjpc/zwab023. Epub 2021 Feb 14.

AIMS : Whether the association between uric acid (UA) and cardiovascular disease is influenced by some facilitating factors is unclear. The aim of this study was to investigate whether the risk of cardiovascular mortality (CVM) associated with elevated UA...

Cite
Palatini P, Parati G, Virdis A, et al. High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. Eur J Prev Cardiol. 2021;doi: 10.1093/eurjpc/zwab023.
Palatini, P., Parati, G., Virdis, A., Reboldi, G., Masi, S., Mengozzi, A., Casiglia, E., Tikhonoff, V., Cicero, A. F. G., Ungar, A., Rivasi, G., Salvetti, M., Barbagallo, C. M., Bombelli, M., Dell'Oro, R., Bruno, B., Lippa, L., D'Elia, L., Verdecchia, P., Angeli, F., Mallamaci, F., Cirillo, M., Rattazzi, M., Cirillo, P., Gesualdo, L., Mazza, A., Giannattasio, C., Maloberti, A., Volpe, M., Tocci, G., Georgiopoulos, G., Iaccarino, G., Nazzaro, P., Galletti, F., Ferri, C., Desideri, G., Viazzi, F., Pontremoli, R., Muiesan, M. L., Grassi, G., Borghi, C. (2021). High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. European journal of preventive cardiology, . https://doi.org/10.1093/eurjpc/zwab023
Palatini, Paolo, et al. "High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid." European journal of preventive cardiology vol. (2021). doi: https://doi.org/10.1093/eurjpc/zwab023
Palatini P, Parati G, Virdis A, Reboldi G, Masi S, Mengozzi A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Verdecchia P, Angeli F, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Georgiopoulos G, Iaccarino G, Nazzaro P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C. High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. Eur J Prev Cardiol. 2021 Feb 14; doi: 10.1093/eurjpc/zwab023. Epub 2021 Feb 14. PMID: 33582757.
Copy Download .nbib Format: NLM
Coffee Consumption and Risk of Adverse Outcomes.

JAMA internal medicine

Palatini P.
PMID: 34842894
JAMA Intern Med. 2022 Jan 01;182(1):94-95. doi: 10.1001/jamainternmed.2021.6920.

No abstract available.

Cite
Palatini P. Coffee Consumption and Risk of Adverse Outcomes. JAMA Intern Med. 2022;182(1):94-95doi: 10.1001/jamainternmed.2021.6920.
Palatini, P. (2022). Coffee Consumption and Risk of Adverse Outcomes. JAMA internal medicine, 182(1), 94-95. https://doi.org/10.1001/jamainternmed.2021.6920
Palatini, Paolo. "Coffee Consumption and Risk of Adverse Outcomes." JAMA internal medicine vol. 182,1 (2022): 94-95. doi: https://doi.org/10.1001/jamainternmed.2021.6920
Palatini P. Coffee Consumption and Risk of Adverse Outcomes. JAMA Intern Med. 2022 Jan 01;182(1):94-95. doi: 10.1001/jamainternmed.2021.6920. PMID: 34842894.
Copy Download .nbib Format: NLM
Coffee Consumption and Risk of Adverse Outcomes.

JAMA internal medicine

Palatini P.
PMID: 34842894
JAMA Intern Med. 2022 Jan 01;182(1):94-95. doi: 10.1001/jamainternmed.2021.6920.

No abstract available.

Cite
Palatini P. Coffee Consumption and Risk of Adverse Outcomes. JAMA Intern Med. 2022;182(1):94-95doi: 10.1001/jamainternmed.2021.6920.
Palatini, P. (2022). Coffee Consumption and Risk of Adverse Outcomes. JAMA internal medicine, 182(1), 94-95. https://doi.org/10.1001/jamainternmed.2021.6920
Palatini, Paolo. "Coffee Consumption and Risk of Adverse Outcomes." JAMA internal medicine vol. 182,1 (2022): 94-95. doi: https://doi.org/10.1001/jamainternmed.2021.6920
Palatini P. Coffee Consumption and Risk of Adverse Outcomes. JAMA Intern Med. 2022 Jan 01;182(1):94-95. doi: 10.1001/jamainternmed.2021.6920. PMID: 34842894.
Copy Download .nbib Format: NLM
[No title available]

Plants (Basel, Switzerland)

Adams TK, Masondo NA, Malatsi P, Makunga NP.
PMID: 34685890
Plants (Basel). 2021 Sep 30;10(10). doi: 10.3390/plants10102078.

The development of a protocol for the large-scale production of

Cite
Adams TK, Masondo NA, Malatsi P, et al. . Plants (Basel). 2021;10(10)doi: 10.3390/plants10102078.
Adams, T. K., Masondo, N. A., Malatsi, P., & Makunga, N. P. (2021). . Plants (Basel, Switzerland), 10(10), . https://doi.org/10.3390/plants10102078
Adams, Tristan K, et al. "." Plants (Basel, Switzerland) vol. 10,10 (2021). doi: https://doi.org/10.3390/plants10102078
Adams TK, Masondo NA, Malatsi P, Makunga NP. . Plants (Basel). 2021 Sep 30;10(10). doi: 10.3390/plants10102078. PMID: 34685890; PMCID: PMC8537884.
Copy Download .nbib Format: NLM
Validation of the Greek Version of Tinnitus Handicap Inventory.

Audiology research

Papitsi I, Balatsouras DG, Makris ID, Koukoutsis G, Kaberos A, Tzavara C, Nikolopoulos T, Sarafis P.
PMID: 33704121
Audiol Res. 2020 Oct 06;10(2):39-48. doi: 10.4081/audiores.2020.244.

PURPOSE: The purpose of this study was to validate the Greek version of the Tinnitus Handicap Inventory.METHOD: Eighty-six adult patients with chronic tinnitus participated in the study. Sociodemographic data and medical history were recorded during the interview. The patients...

Cite
Papitsi I, Balatsouras DG, Makris ID, et al. Validation of the Greek Version of Tinnitus Handicap Inventory. Audiol Res. 2020;10(2):39-48doi: 10.4081/audiores.2020.244.
Papitsi, I., Balatsouras, D. G., Makris, I. D., Koukoutsis, G., Kaberos, A., Tzavara, C., Nikolopoulos, T., & Sarafis, P. (2020). Validation of the Greek Version of Tinnitus Handicap Inventory. Audiology research, 10(2), 39-48. https://doi.org/10.4081/audiores.2020.244
Papitsi, Isidora, et al. "Validation of the Greek Version of Tinnitus Handicap Inventory." Audiology research vol. 10,2 (2020): 39-48. doi: https://doi.org/10.4081/audiores.2020.244
Papitsi I, Balatsouras DG, Makris ID, Koukoutsis G, Kaberos A, Tzavara C, Nikolopoulos T, Sarafis P. Validation of the Greek Version of Tinnitus Handicap Inventory. Audiol Res. 2020 Oct 06;10(2):39-48. doi: 10.4081/audiores.2020.244. PMID: 33704121; PMCID: PMC7768439.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 88 entries